Cole Hugh M Insider Trades

Insider Trading History

Track insider trading activity for Cole Hugh M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1M 79,749 shares
$12.58
$12.58
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $334k 26,550 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$154k 26,550 shares
$5.79
$12.58
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $177k 14,100 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 14,100 shares
$9.18
$12.58
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $177k 14,100 shares
Last Trade
Jun 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$160k 14,100 shares
$11.35
$12.58
Jounce Therapeutics
Jounce Therapeutics JNCE
Chief Operating Officer
Holding Value $207k 110,082 shares
Last Trade
Jan 10, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.3k 9,182 shares
$1.12
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Chief Operating Officer
Holding Value $224k 119,264 shares
Last Trade
Jan 09, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$8.2k 7,452 shares
$1.10
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Chief Operating Officer
Holding Value $75.2k 40,000 shares
Last Trade
Aug 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$119k 40,000 shares
$2.97
$1.88
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $105k 8,333 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25k 8,333 shares
$3.00
$12.58
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $105k 8,333 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25k 8,333 shares
$3.00
$12.58
Jounce Therapeutics
Jounce Therapeutics JNCE
Chief Business Officer
Holding Value $201k 106,716 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$964k 127,500 shares
$7.56
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Chief Business Officer
Holding Value $160k 85,000 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$643k 85,000 shares
$7.56
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Chief Business Officer
Holding Value $121k 64,216 shares
Last Trade
Jan 10, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$41.3k 6,205 shares
$6.65
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Chief Business Officer
Holding Value $132k 70,421 shares
Last Trade
Jan 07, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$25.3k 3,468 shares
$7.30
$1.88
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals CATB
Director
Holding Value $854k 100,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 100,000 shares
$12.24
$8.54
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $1.26M 100,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$12.58
Jounce Therapeutics
Jounce Therapeutics JNCE
Chief Business Officer
Holding Value $139k 73,889 shares
Last Trade
Feb 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$952k 80,100 shares
$11.89
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Chief Business Officer
Holding Value $88.7k 47,189 shares
Last Trade
Jan 22, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$215k 18,000 shares
$11.95
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Chief Business Officer
Holding Value $123k 65,189 shares
Last Trade
Jan 22, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$126k 10,000 shares
$12.55
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Chief Business Officer
Holding Value $103k 55,000 shares
Last Trade
Jan 22, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$126k 10,000 shares
$12.55
$1.88
Jounce Therapeutics
Jounce Therapeutics JNCE
Chief Business Officer
Holding Value $104k 55,189 shares
Last Trade
Jan 08, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$23.4k 3,340 shares
$7.00
$1.88

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up